These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 8455694)

  • 1. Atrial systolic failure in cardiac amyloidosis.
    Seino Y; Hayakawa H
    N Engl J Med; 1993 Apr; 328(16):1198; author reply 1198-9. PubMed ID: 8455694
    [No Abstract]   [Full Text] [Related]  

  • 2. Atrial systolic failure in cardiac amyloidosis.
    de Freitas AF; Costa PP
    N Engl J Med; 1993 Apr; 328(16):1198; author reply 1198-9. PubMed ID: 8455693
    [No Abstract]   [Full Text] [Related]  

  • 3. Brief report: atrial systolic failure in primary amyloidosis.
    Plehn JF; Southworth J; Cornwell GG
    N Engl J Med; 1992 Nov; 327(22):1570-3. PubMed ID: 1435884
    [No Abstract]   [Full Text] [Related]  

  • 4. Atrial systolic failure in cardiac amyloidosis.
    Stables RH; Ormerod OJ
    Q J Med; 1993 Jul; 86(7):465-6. PubMed ID: 8280268
    [No Abstract]   [Full Text] [Related]  

  • 5. Atrial amyloidosis and atrial fibrillation: a gender-dependent "arrhythmogenic substrate"?
    Goette A; Röcken C
    Eur Heart J; 2004 Jul; 25(14):1185-6. PubMed ID: 15246635
    [No Abstract]   [Full Text] [Related]  

  • 6. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.
    Passino C; Maria Sironi A; Favilli B; Poletti R; Prontera C; Ripoli A; Lombardi M; Emdin M
    Int J Cardiol; 2005 Sep; 104(1):39-45. PubMed ID: 16137508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain natriuretic peptide: is it a predictor of cardiomyopathy in cirrhosis?
    Wong F; Siu S; Liu P; Blendis LM
    Clin Sci (Lond); 2001 Dec; 101(6):621-8. PubMed ID: 11724649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal proatrial natriuretic peptide and prognosis in patients with heart failure and preserved systolic function.
    Andersson B; Hall C
    J Card Fail; 2000 Sep; 6(3):208-13. PubMed ID: 10997746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Systemic embolism and thrombosis of the left atrium in a patient in sinus rhythm with cardiac amyloidosis].
    Roudaut R; Pepin C; Marazanof M; Bonnet J
    Ann Cardiol Angeiol (Paris); 1996 Mar; 45(3):119-21. PubMed ID: 8762913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial pathology in cardiac amyloidosis: evidence from ECG and cardiovascular magnetic resonance.
    Leeson CP; Myerson SG; Walls GB; Neubauer S; Ormerod OJ
    Eur Heart J; 2006 Jul; 27(14):1670. PubMed ID: 16449244
    [No Abstract]   [Full Text] [Related]  

  • 11. Left atrial myopathy in cardiac amyloidosis: implications of novel echocardiographic techniques.
    Modesto KM; Dispenzieri A; Cauduro SA; Lacy M; Khandheria BK; Pellikka PA; Belohlavek M; Seward JB; Kyle R; Tajik AJ; Gertz M; Abraham TP
    Eur Heart J; 2005 Jan; 26(2):173-9. PubMed ID: 15618074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloidosis and cardiac involvement.
    Cacoub P; Axler O; De Zuttere D; Hausfater P; Amoura Z; Walter S; Wechsler B; Godeau P; Piette JC
    Ann Med Interne (Paris); 2000 Dec; 151(8):611-7. PubMed ID: 11173703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Type B natriuretic peptide in the diagnosis of heart failure with preserved systolic function].
    Castro A; Dias P; Pereira M; Pimenta J; Friões F; Rodrigues R; Ferreira A; Bettencourt P
    Rev Port Cardiol; 2001 Nov; 20(11):1109-13. PubMed ID: 11826702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local amyloidosis as a possible component of the atrial remodeling accompanying atrial fibrillation [corrected].
    Leone O; Boriani G; Marinelli G; Rapezzi C
    J Am Coll Cardiol; 2008 Jun; 51(25):2444-5; author reply 2445. PubMed ID: 18565406
    [No Abstract]   [Full Text] [Related]  

  • 15. Atrial enhancement by cardiovascular magnetic resonance in cardiac amyloidosis.
    Lyne JC; Petryka J; Pennell DJ
    Eur Heart J; 2008 Jan; 29(2):212. PubMed ID: 17704093
    [No Abstract]   [Full Text] [Related]  

  • 16. Recombinant bovine growth hormone-induced reduction of atrial natriuretic peptide is associated with improved left ventricular contractility and reverse remodeling in cardiomyopathic UM-X7.1 hamsters with congestive heart failure.
    Mulumba M; Céméus C; Dumont L; du Souich P; Ong H; Marleau S
    Growth Horm IGF Res; 2007 Apr; 17(2):96-103. PubMed ID: 17280860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of noradrenaline and atrial natriuretic hormone concentration in blood serum of pharmacologically untreated patients with chronic heart failure].
    Jabłecka A
    Przegl Lek; 1999; 56(10):660-3. PubMed ID: 10695381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis of systolic heart failure].
    André-Fouët X; Ginon I; Thivolet S
    Rev Prat; 2002 Oct; 52(15):1644-9. PubMed ID: 12434592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experiences with serum BNP (B type natriuretic peptide) in patients with systolic and diastolic heart failure].
    Lukács I; Fey E; Kárpáti P
    Orv Hetil; 2005 Sep; 146(37):1919-23. PubMed ID: 16255376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The premortem recognition of systemic senile amyloidosis with cardiac involvement.
    Kyle RA; Spittell PC; Gertz MA; Li CY; Edwards WD; Olson LJ; Thibodeau SN
    Am J Med; 1996 Oct; 101(4):395-400. PubMed ID: 8873510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.